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264 Relationship between the chest excursion and lung function,
functional capacity and peripheral muscle strength in patients
with cystic ﬁbrosis
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Aim: Measurement of chest excursion is used to evaluate lung expansion from three
different thoracic regions. The aim of the study was to investigate the relationship
between chest excursion and lung function, functional capacity and upper extremity
muscle strength in clinicaly stable cystic ﬁbrosis (CF) patients.
Methods: Twenty-eight (18 males, 10 females) patients, the aged 7−21 years,
with CF participated in the study. Pulmonary function test was performed using
spirometry. Chest excursion was measured using a tape measure from axillar,
subcostal, and epigastric regions. Functional capacity was evaluated with six-
minute walk test (6MWT). Upper extremity muscle strength (shoulder ﬂexion
and abduction, elbow ﬂexion, and hand grip strength) was evaluated using digital
dynamometer.
Results: The mean FEV1 was 85.80±23.44%. Chest excursion from axillar region
was signiﬁcantly correlated with FVC (r = 0.61), FEV1 (r = 0.66), PEF (r = 0.63),
FEF25−75% (r = 0.58), 6MWT distance (r = 0.39), shoulder ﬂexion (r = 0.40) and
abduction (r = 0.41), elbow ﬂexion (r = 0.54), and hand grip strength (r = 0.59,
p< 0.05). Chest excursion from epigastric region was statistically related with
FVC (r = 0.59), FEV1 (r = 0.58), PEF (r = 0.57), FEF25−75% (r = 0.48), 6MWT
distance (r = 0.41), shoulder ﬂexion (r = 0.44) and abduction (r = 0.42), elbow ﬂex-
ion (r = 0.49), and hand grip strength (r = 0.55, p< 0.05). Chest excursion from
subcostal region was signiﬁcantly correlated with FEV1 (r = 0.39), PEF (r = 0.38),
and FEF25−75% (r = 0.39, p< 0.05).
Conclusion: Chest excursion measurement from upper thorax was signiﬁcantly
correlated with lung function, functional capacity and upper extremity muscle
strength. Increasing chest mobility was associated with increased functional capacity
and upper extremity training. Therefore measurement chest mobility should be
included in comprehensive evaluation of cystic ﬁbrosis patients.
265 The development and validation of the incremental step test (IST)
in children with cystic ﬁbrosis (CF)
H.J. Holden1, S. Mockett2, A.R. Smyth3. 1Nottingham University Hospitals
NHS Trust, Physiotherapy Dept, QMC Campus, Nottingham, United Kingdom;
2University of Nottingham, Division of Physiotherapy Education, Nottingham,
United Kingdom; 3University of Nottingham, School of Clinical Sciences,
Nottingham, United Kingdom
Children with CF are often now as physically active as their healthy peers, so an
appropriate ﬁeld based exercise test in the absence of maximal exercise testing
facilities is essential. The aim of the study was to develop a simple incremental
externally paced step test, to assess exercise tolerance to a symptom-limited
maximum. The study investigated the reproducibility and validity of the IST with the
six minute walk test (6MWT) in 14 children with CF. Subjects performed both tests
on two occasions in a randomised cross-over design. Measurements of pulmonary
function heart rate (HR), oxygen saturations (SaO2) and blood pressure (BP) were
recorded, as well as measures of perceived exertion (visual analogue scale (VAS),
OMNI scale and 15-count score). Twelve subjects (6 male) with a mean age of
10.8 years (range 7−16 years), and a mean FEV1 83.7% predicted (range 51%-
134%) completed the study. The IST demonstrated a signiﬁcant and high measure
of reliability (r = 0.70, p = 0.004), and reproducibility (r = 0.84, p = 0.001) and signif-
icantly correlated well with the distance achieved in the 6MWT (r = 0.74, p = 0.006).
The IST was physically more demanding, producing a signiﬁcantly higher HR
(p = 0.003), HRmax (p = 0.002) and percent predicted HRmax (p = 0.001). This was
supported by the subjects with signiﬁcantly greater VAS (p = 0.004) and OMNI
scores (p = 0.002). The IST was able to detect a signiﬁcant fall in median SaO2
(0.5%, p = 0.034) in these mild to moderate CF children unlike the 6MWT. This
study demonstrated the IST to be reproducible, reliable and a valid functional ﬁeld
test of exercise tolerance in this sample of CF children.
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Background: The 6 minute walk test is a validated and widely used test in
CF.Distances under 400m are associated with poorer outcomes. The test needs
signiﬁcant space to carry out. A 12 minute incremental step test has been validated
for use in children with CF [1]. The aim of the study was to investigate whether
there was any correlation between the 6 minute walk test and 12 minute step test.
The Pearson’s Coefﬁcient of Correlation (r) was used to measure the correlation.
The end point to the step test is 312 steps. All those completing the step test were
taken out of the correlation analysis. The end point for the walk test is completing
the full 6 minutes and the outcome is the total distance walked. No patients had to
stop or rest during the walk test.
Outcome: A total of 34 walk tests and step tests were carried out. The correlation
co-efﬁcient statistic for those not completing the step test between the two tests
was 0.4 at a level of signiﬁcance of 0.06. Subjects who completed the step test
also performed satisfactorily on the walk test, with the minimum distance walked
at 460m and a mean of 515m with a standard deviation of 34m.
Conclusion: For those patients who complete the step test it can be predicted that
they would also do well in the walk test. It should be noted that the number of
cases in the data was small, but for those that did not complete the step test the
data analysed suggests the Step test cannot be used to predict the walk test. The
12 minute incremental step test may provide useful information if the facilities for
a 6 minute walk test are not available.
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Exercise is recommended in consensus documents regarding health care manage-
ment of people with CF, however the relationship between exercise participation
and health outcomes for CF adults is unclear. We aimed to compare demographics,
quality of life, lung function and hospitalisation rates for CF adults, according to
exercise participation. 101 (17−62 yr; 58 male; FEV1 15–109%) adults from the
RPAH CF Clinic reported their exercise participation in an un-named questionnaire
when clinically stable. Participants were prospectively allocated to a high or low
activity group if they performed more or less than 90 minutes of moderate/strenuous
exercise per week at baseline. Quality of life was measured at baseline and at
3 months follow-up. Lung function and hospitalisation data were collected from
Clinic records at baseline and at 12 months follow-up. 68 (67%) adults were
allocated to the high activity and 33 (33%) to the low activity group. There were
no differences in age, gender or lung function between the high and low activity
groups at baseline. The high activity group had signiﬁcantly higher quality of life
at baseline and follow-up than the low activity group. There was no signiﬁcant
difference in the change in FEV1 from baseline to follow-up between the two
groups, however females in the low activity group had more than six times greater
annual decline in FEV1 than their high activity female peers. The high activity
group had signiﬁcantly fewer days in hospital during the 12 month follow-up than
the low activity group. This result was independent of baseline FEV1. Exercise
has the potential to improve quality of life and reduce hospitalisation rates for CF
adults.
